Advances in Pharmacology: Catecholamines Bridging Basic Science with Clinical Medicine

, by Goldstein, David S.; Eisenhofer, Graeme; McCarty, Richard

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

ISBN: 9780120329434 | 0120329433
Cover: Hardcover
Copyright: 11/1/1998

eBook

Available Instantly

Online: 1825 Days

Downloadable: Lifetime Access

*To support the delivery of the digital material to you, a digital delivery fee of $3.99 will be charged on each digital item.

$312.00*

Summary

Supplemental Materials

This volume in Advances in Pharmacology focuses on all aspects of catecholamine research, from very basic to medical. It is broad based and covers many areas within physiology and medicine.

Contributors

xxix

(12)

Preface

xli

PART A CATECHOLAMINE SYNTHESIS AND RELEASE

(148)

Overview

(14)

Toshi Nagatsu

Lennart Stjarne

Regulation and Expression of Tyrosine Hydroxylase

(38)

The Effect of Phosphorylation at Ser-40 on the Structure and Thermal Stability of Tyrosine Hydroxylase

(3)

Arturo Muga

Jose Luis R. Arrondo

Aurora Martinez

Torgier Flatmark

Jan Haavik

Factors Affecting Adrenal Medullary Catecholamine Biosynthesis and Release

(3)

Nobuyuki Yanagihara

Futoshi Izumi

Eishichi Miyamoto

Motoo Oka

Regulation of Tyrosine Hydroxylase by Neuropeptides

(4)

Richard E. Zigmond

Regulation of Tyrosine Hydroxylase Gene Expression by Transsynaptic Mechanisms and Cell-Cell Contact

(5)

A. William Tank

Kristen M. Piech

Cheryl A. Osterhout

Baoyong Sun

Carol Sterling

A New Regulatory Protein of Catecholamine Synthesizing-Enzyme Expression

(3)

Tohru Yamakuni

Toshibumi Yamamoto

Masato Hoshino

Hideko Yamamoto

Si-Young Song

Mayuko Kunikata-Sumitomo

Shiro Konishi

Unique and Cell-Type-Specific Tyrosine Hydroxylase Gene Expression

(4)

T. H. Joh

J. H. Son

C. Tinti

B. Conti

S. J. Kim

S. Cho

*Triple Colocalization of Tyrosine Hydroxylase, Calretinin, and Calbindin D-28k in the Periventricular-Hypophyseal Dopaminergic Neuronal System

(4)

D. M. Jacobowitz

K. R. Isaacs

V. Cimini

*Genetic Disorders Involving Recycling and Formation of Tetrahydrobiopterin

(3)

Seymour Kaufman

Genetic Basis of Dominant Dystonia

(4)

T. Nagatsu

H. Ichinose

Mutations in the Tyrosine Hydroxylase Gene Cause Various Forms of L-Dopa-Responsive Dystonia

(2)

Klaus Bartholome

Barbara Ludecke

Catecholamine Biosynthetic Enzyme Expression in Neurological and Psychiatric Disorders

(3)

Rolando Meloni

Sylvie Dumas

Jacques Mallet

Other Catecholamine-Synthesizing Enzymes

(96)

*Multiple Pathways in Regulation of Dopamine Beta-Hydroxylase

(4)

Esther L. Sabban

Bistra B. Nankova

Examining Adrenergic Roles in Development, Physiology, and Behavior through Targeted Disruption of the Mouse Dopamine Beta-Hydroxylase Gene

(4)

Steven A. Thomas

Richard D. Palmiter

Genetic Diseases of Hypotension

(5)

David Robertson

Nannette Hale

*Dopamine Beta-Hydroxylase Deficiency Associated with Mutations in a Copper Transporter Gene

(3)

Stephen G. Kaler

Courtney S. Holmes

David S. Goldstein

Glucocorticoid-Phenylethanolamine-N-methyltransferase Interactions in Humans

(4)

M. Mannelli

R. Lanzillotti

C. Pupilli

L. Ianni

A. Natali

F. Bellini

Determinants of Phenylethanolamine-N-methyltransferase Expression

(4)

M. J. Evinger

Neural Control of Phenylethanolamine-N-methyltransferase via Cholinergic Activation of Egr-1

(4)

Dona L. Wong

Steven N. Ebert

Kyoji Morita

Synexin (Annexin VII) Hypothesis for Ca(2+)/GTP-Regulated Exocytosis

(6)

Harvey B. Pollard

Hung Caohuy

Allen P. Minton

Meera Srivastava

Monoamine Transmitter Release from Small Synaptic and Large Dense-Core Vesicles

(4)

Dieter Bruns

Reinhard Jahn

Calcium Channels for Exocytosis in Chromaffin Cells

(4)

Antonio G. Garcia

Almundena Albillos

Maria F. Cano-Abad

Esther Garcia-Palomero

M. Hernandez-Guijo

Carlos J. Herrero

Richard B. Lomax

Luis Gandia

Characteristics of Transmitter Secretion from Individual Sympathetic Varicosities

(3)

T. C. Cunnane

A. Smith

Neurotransmitter Release at Individual Sympathetic Varicosities, Boutons

(4)

M. R. Bennett

Appropriate Target Cells Are Required for Maturation of Neurotransmitter Release Function of Sympathetic Neurons in Culture

102

(4)

Arun R. Wakade

Dennis Przywara

Taruna D. Wakade

Effects of Neuropeptide Y at Sympathetic Neuroeffector Junctions

106

(4)

Thomas C. Westfall

Laura A. McCullough

Lillian Vickery

Linda Naes

Chun Lian

Yang, Song-Ping Han

Terry Egan

Xiaoli Chen

Heather MacArthur

Strategies for Receptor Control of Neurotransmitter Release

110

(4)

David G. Nicholls

Pattern of Adenosine Triphosphate and Norepinephrine Release and Clearance: Consequences for Neurotransmission

114

(6)

Lennart Stjarne

Corelease of Norepinephrine and Adenosine Triphosphate from Sympathetic Neurones

120

(5)

Ivar von Kugelgen

Jorge Goncalves

Bernd Driessen

Klaus Starke

*Neuropeptide Y: An Adrenergic Cotransmitter, Vasoconstrictor, and a Nerve-Derived Vascular Growth Factor

125

(4)

Zofia Zukowska-Grojec

*Neuropeptide Y: A Cardiac Sympathetic Cotransmitter?

129

(4)

Markus Haass

Biochemistry of Somatodendritic Dopamine Release in Substantia Nigra: An in Vivo Comparison with Striatal Dopamine Release

133

(3)

Elizabeth D. Abercrombie

Peter DeBoer

Marten J. Heeringa

The Use of Dual-Probe Microdialysis for the Study of Catecholamine Release in the Brain and Pineal Gland

136

(4)

B. H. C. Westerink

W. J. Drijfhout

M. vanGalen

Y. Kawahara

H. Kawahara

Kinetics and Geometry of the Excitatory Dopaminergic Transmission in the Rat Striatum in Vivo

140

(4)

F. Gonon

B. Bloch

In Vivo and in Vitro Assessment of Dopamine Uptake and Release

144

(5)

George E. Mickelson

Paul A. Garris

Melissa Bunin

R. Mark Wightman

PART B CATECHOLAMINE REUPTAKE AND STORAGE

149

(124)

Overview

149

(15)

Heinz Bonisch

Lee Eiden

The Plasma Membrane Transporters

164

(59)

Molecular Physiology and Regulation of Catecholamine Transporters

164

(4)

S. G. Amara

M. S. Sonders

N. R. Zahniser

S. L. Povlock

G. M. Daniels

Localization of Dopamine Transporter Protein by Microscopic Histochemistry

168

(3)

M. J. Kuhar

R. Vaughan

G. Uhl

C. Cerruti

R. Revay

C. Freed

M. Nirenburg

V. Pickel

Cellular and Subcellular Localization of the Dopamine Transporter in Rat Cortex

171

(4)

Susan R. Sesack

Valerie A. Hawrylak

Margaret A. Guido

Allan I. Levey

Cloned Catecholamine Transporters Expressed in Polarized Epithelial Cells: Sorting, Drug Sensitivity, and Ion-Coupling Stoichiometry

175

(4)

H. Gu

M. J. Caplan

G. Rudnick

Inactivation of the Dopamine Transporter Reveals Essential Roles of Dopamine in the Control of Locomotion, Psychostimulant Response, and Pituitary Function

179

(4)

Fabio Fumagalli

Sara Jones

Roger Bosse

Mohamed Jaber

Bruno Giros

Cristina Missale

R. Mark Wightman

Marc G. Caron

Role of Protein Kinase C and Second Messengers in Regulation of the Norepinephrine Transporter

183

(3)

H. Bonisch

R. Hammermann

M. Bruss

Electrophysiological Analysis of Transporter Function

186

(5)

Louis J. DeFelice

Aurelio Galli

Voltammetric Approaches to Kinetics and Mechanism of the Norepinephrine Transporter

191

(4)

J. B. Justice

K. S. Danek

J. W. Kable

E. L. Barker

R. D. Blakely

Voltage-Dependency of the Dopamine Transporter in Rat Brain

195

(3)

N. R. Zahniser

G. A. Gerhardt

A. F. Hoffman

C. R. Lupica

Modulation of Quantal Dopamine Release by Psychostimulants

198

(4)

Emmanuel N. Pothos

David Sulzer

Regulation of Dopamine Transporter mRNA Levels in the Central Nervous System

202

(4)

Beth J. Hoffman

Miklos Palkovits

Karel Pacak

Stefan R. Hansson

Eva Mezey

Structural Diversity in the Catecholamine Transporter Gene Family: Molecular Cloning and Characterization of an L-Epinephrine Transporter from Bullfrog Sympathetic Ganglia

206

(5)

Randy D. Blakely

Subramaniam Apparsundaram

Positron Emission Tomography Radiogands for Dopamine Transporters and Studies in Human and Nonhuman Primates

211

(4)

N. D. Volkow

J. S. Fowler

Y-S. Ding

G-J. Wang

S. J. Gatley

Single Photon Emission Computed Tomography Imaging of Dopaminergic Function: Presynaptic Transporter, Postsynaptic Receptor, and "Intrasynaptic" Transmitter

215

(4)

Robert B. Innis

Dopamine Transporter Changes in Neuropsychiatric Disorders

219

(4)

D. F. Wong

G. Ricaurte

G. Grunder

R. Rothman

S. Naidu

H. Singer

J. Harris

F. Yokoi

V. Villemagne

S. Szymanski

A. Gjedde

M. Kuhar

Vesicular Transporters and Catecholamine Storage

223

(50)

Molecular and Biochemical Studies of Rat Vesicular Monoamine Transporter

223

(4)

Shimon Schuldiner

Sonia Steiner-Mordoch

Rodrigo Yelin

A Chimeric Vesicular Monoamine Transporter Dissociates Sensitivity to Tetrabenazine and Unsubstituted Aromatic Amines

227

(5)

J. D. Erickson

Ligand Recognition by the Vesicular Monoamine Transporters

232

(4)

J. P. Finn

A. Merickel

D. Peter

R. H. Edwards

Molecular Pharmacology of the Vesicular Monoamine Transporter

236

(4)

J. P. Henry

C. Sagne

D. Botton

M. F. Isambert

B. Gasnier

Ultrastructural Localization of the Vesicular Monoamine Transporter 2 in Mesolimbic and Nigrostriatal Dopaminergic Neurons

240

(3)

Melissa J. Nirenberg

June Chan

Yongjian Liu

Robert H. Edwards

Virginia M. Pickel

ICA 512, Receptor Tyrosine Phosphatase-Like Protein, Is Concentrated in Neurosecretory Granule Membranes

243

(4)

R. Dirkx

J-M. Hermel

D. U. Rabin

M. Solimena

Protein Targeting in Neurons and Endocrine Cells

247

(3)

A. E. West

C. Provoda

R. L. Neve

K. M. Buckley

The Vesicular Monoamine Transporter VMAT2 and Vesicular Acetylcholine Transporter VAChT Are Sorted to Separate Vesicle Populations in PC12 Cells

250

(3)

J-H. Tao-Cheng

L. E. Eiden

Recycling of Synaptic Vesicles

253

(4)

Rudolf Bauerfeind

Carol David

Detlev Grabs

Peter S. McPherson

Yasuo Nemoto

Vladimir I. Slepnev

Kohji Takei

Pietro De Camilli

The Secretory Cocktail of Adrenergic Large Dense-Core Vesicles: The Functional Role of the Chromogranins

257

(3)

H. Winkler

A. Laslop

B. Leitner

C. Weiss

A Novel, Catecholamine Release-Inhibitory Peptide from Chromogranin A: Autocrine Control of Nicotinic Cholinergic-Stimulated Exocytosis

260

(4)

Sushil K. Mahata

Manjula Mahata

Seung Hyun Yoo

Laurent Taupenot

Hongjiang Wu

Vanita R. Aroda

Carolyn V. Livsey

Joseph P. Taulane

Murray Goodman

Robert J. Parmer

Daniel T. O'Connor

Transcription Regulation Coupled to Calcium and Protein Kinase Signaling Systems through TRE- and CRE-Like Sequences in Neuropeptide Genes

264

(5)

Lee E. Eiden

Youssef Anouar

Chang-Mei Hsu

Linda MacArthur

Sung Ho Hahm

Imaging of Monoaminergic and Cholinergic Vesicular Transporters in the Brain

269

(4)

Kirk A. Frey

Donald M. Wieland

Michael R. Kilbourn

PART C CATECHOLAMINE METABOLISM: FROM MOLECULAR UNDERSTANDING TO CLINICAL DIAGNOSIS AND TREATMENT

273

(106)

Overview

273

(19)

Alan A. Boulton

Graeme Eisenhofer

Monoamine Oxidase

292

(32)

Monoamine Oxidase A and B: Structure, Function, and Behavior

292

(5)

Kevin Chen

Jean Chen Shih

*Genetic Deficiencies of Monoamine Oxidase Isoenzymes: A Key to Understanding the Function of the Enzymes in Humans

297

(4)

Jacques W. M. Lenders

Han G. Brunner

Dennis L. Murphy

Graeme Eisenhofer

Biological Markers, with Special Regard to Platelet Monoamine Oxidase (trbc-MAO), for Personality and Personality Disorders

301

(3)

Lars Oreland

Jonas Ekblom

Hakan Garpenstrand

Jarmila Hallman

Visualization of Monoamine Oxidase in Human Brain

304

(4)

J. S. Fowler

N. D. Volkow

G. J. Wang

N. Pappas

C. Shea

R. R. MacGregor

J. Logan

Aliphatic N-Methylpropargylamines: Monoamine Oxidase-B Inhibitors and Antiapoptotic Drugs

308

(4)

Alan A. Boulton

Peter H. Yu

Bruce A. Davis

I. Alick Paterson

Xi-Min Li

Augusto V. Juorio

David A. Durden

Lillian E. Dyck

Antiapoptotic Actions of Monoamine Oxidase B Inhibitors

312

(4)

I. A. Paterson

W. G. Tatton

Therapeutic Actions of L-Deprenyl in Dogs: A Model of Human Brain Aging

316

(4)

W. W. Ruehl

J. Neilson

B. Hart

E. Head

D. S. Bruyette

B. J. Cummings

Apomorphine Is a Potent Radical Scavenger and Protects Cultured Pheochromocytoma Cells from H(2)O(2)-Induced Cell Death

320

(4)

M. Gassen

B. Pinchasi

M. B. H. Youdim

O-Methylation and Conjugation

324

(22)

Catechol O-Methyltransferase: Characterization of the Protein, Its Gene, and the Preclinical Pharmacology of COMT Inhibitors

324

(4)

Pekka T. Mannisto

X-Ray Crystallography of Catechol O-Methyltransferase: Perspectives for Target-Based Drug Development

328

(3)

Jukka Vidgren

Catechol O-Methyltransferase Inhibition and the Treatment of Parkinson's Disease

331

(4)

John G. Nutt

The Structure and Function of the UDP-Glucuronosyltransferase Gene Family

335

(4)

B. Burchell

C. H. Brierley

G. Monaghan

D. J. Clarke

Catecholamine Sulfation in Health and Disease

339

(4)

Michael W. H. Coughtrie

Metabolism of Endobiotics and Xenobiotics by UDP-Glucuronosyltransferase

343

(3)

T. R. Tephly

M. D. Green

B. L. Coffman

C. King

Z. Cheng

G. Rios

Catecholamine Metabolizing Systems

346

(33)

Molecular Structure of the Carrier Responsible for Hepatic Uptake of Catecholamines

346

(4)

Dirk Grundemann

Tilo Breidert

Folker Spitzenberger

Edgar Schomig

Catecholamine Uptake and Metabolism in the Liver

350

(3)

Fatima Martel

Catecholamine Uptake and Metabolism in Rat Lungs

353

(3)

Lesley J. Bryan-Lluka

Kristy M. James

Heinz Bonisch

Peter Porzgen

Karen S. Guice

Keith T. Oldham

The Extraneuronal Monoamine Transporter Exists in Human Central Nervous System Glia

356

(4)

Edgar Schomig

Hermann Russ

Kerstin Staudt

Fatima Martel

Martin Gliese

Dirk Grundemann

Removal of Circulating Catecholamines by Extraneuronal Amine Transport Systems

360

(4)

Karl-Heinz Graefe

Bernd Friedgen

Reinhard Wolfel

Edgar Schomig

Catecholamine Metabolites in Internal Jugular Plasma: A Window into the Human Brain

364

(3)

G. W. Lambert

D. M. Kaye

J. M. Thompson

A. G. Turner

C. Ferrier

H. S. Cox

M. Vaz

D. Wilkinson

I. T. Meredith

G. L. Jennings

M. D. Esler

Norepinephrine Metabolites in Plasma as Indicators of Pharmacological Inhibition of Monoamine Oxidase and Catechol O-Methyltransferase

367

(3)

Mika Scheinin

Ari Illi

Markku Koulu

Pirjo Ojala-Karlsson

The Adrenal Gland as a Source of Dihydroxyphenylalanine and Catecholamine Metabolites

370

(4)

G. M. Tyce

S. L. Chritton

R. D. Barnes

L. E. Ward

L. W. Hunter

D. K. Rorie

*Clues to the Diagnosis of Pheochromocytoma from the Differential Tissue Metabolism of Catecholamines

374

(5)

Graeme Eisenhofer

Jacques W. M. Lenders

PART D CATECHOLAMINE RECEPTORS AND SIGNAL TRANSDUCTION

379

(150)

Overview

379

(11)

David S. Goldstein

Structure, Classification, and Tissue Localization of Catecholamine Receptor Subtypes

390

(26)

Expression and Regulation of Alpha(1)-Adrenergic Receptors in Human Tissues

390

(4)

Debra A. Schwinn

Madan M. Kwatra

Alpha(1)-Adrenoceptor Subtypes in the Human Cardiovascular and Urogenital Systems

394

(4)

Martin C. Michel

Katsunari Taguchi

Rafael S. Schafers

Timothy J. Williams

David E. Clarke

Anthony P. D. W. Ford

Molecular Mechanisms of Ligand Binding and Activation of Alpha(1)-Adrenergic Receptors

398

(6)

Dianne M. Perez

John Hwa

Ming-Ming Zhao

James Porter

Expansion of the Dopamine D1 Receptor Gene Family: Defining Molecular, Pharmacological, and Functional Criteria for D1A, D1B, D1C, and D1D Receptors

404

(4)

Hyman B. Niznik

Fang Liu

Kim S. Sugamori

Bruno Cardinaud

Phillipe Vernier

D1/D3 Receptor Relationships in Brain: Coexpression, Coactivation, and Coregulation

408

(4)

J-C. Schwartz

S. Ridray

R. Bordet

J. Diaz

P. Sokoloff

Mapping the Binding-Site Crevice of the D2 Receptor

412

(4)

Jonathan A. Javitch

Intracellular Mechanisms

416

(54)

Mechanisms of Beta-Adrenergic Receptor Desensitization and Resensitization

416

(4)

Robert J. Lefkowitz

Julie Pitcher

Kathleen Krueger

Yehia Daaka

Role of Beta-Arrestins in the Intracellular Trafficking of G-Protein-Coupled Receptors

420

(5)

Stephen S. G. Ferguson

Jie Zhang

Larry S. Barak

Marc G. Caron

G-Protein-Linked Receptors as Substrates for Tyrosine Kinases: Cross-Talk in Signaling

425

(4)

Vijaya Karoor

Craig C. Malbon

Role of Arrestins in G-Protein-Coupled Receptor Endocytosis

429

(4)

Oscar B. Goodman, Jr.

Jason G. Krupnick

Francesca Santini

Vsevolod V. Gurevich

Raymond B. Penn

Alison W. Gagnon

James H. Keen

Jeffrey L. Benovic

Subtype-Specific Regulation of the Beta-Adrenergic Receptors

433

(5)

Michel Bouvier

Guy Rousseau

Structural Determinants of Alpha(2)-Adrenergic Receptor Regulation

438

(5)

Stephen B. Liggett

*Regulation of D2 and D3 Receptors in Transfected Cells by Agonists and Antagonists

443

(4)

Kevin D. Burris

Susanne M. Fausing

Perry B. Molinoff

Regulation of the D1 Dopamine Receptor through cAMP-Mediated Pathways

447

(4)

David R. Sibley

Ana L. M. Ventura

Dong Jiang

Chun Mak

Mechanisms for Activation of Multiple Effectors by Alpha(1)-Adrenergic Receptors

451

(3)

Paul A. Insel

Maria A. Balboa

Naoki Mochizuki

Steven R. Post

Kazushi Urasawa

Mingxhao Xing

Signal Transduction Pathways Modulated by D2-Like Dopamine Receptors

454

(4)

Rita M. Huff

Chris L. Chio

Mary E. Lajiness

Linda V. Goodman

Guanosine Triphosphatase-Activating Proteins for Heterotrimetric G-Proteins

458

(4)

Elliott M. Ross

Jun Wang

Yaping Tu

Gloria H. Biddlecome

Regulation of the Stoichiometry of Protein Components of the Stimulatory Adenylyl Cyclase Cascade

462

(4)

G. Milligan

I. Mullaney

G. D. Kim

D. MacEwan

Regulation of Mitogen-Activated Protein Kinase Pathways by Catecholamine Receptors

466

(4)

Louis M. Luttrell

Tim van Biesen

Brian E. Hawes

Gregory J. Della Rocca

Deirdre K. Luttrell

Robert J. Lefkowitz

Pharmacology

470

(23)

Examination of Ligand-Induced Conformational Changes in the Beta(2)-Adrenergic Receptor by Fluorescence Spectroscopy

470

(4)

Brian K. Kobilka

Ulrik Gether

Relationship between Alpha(2)-Adrenergic Receptors and Imidazoline/Guanidinium Receptive Sites

474

(4)

Stephen M. Lanier

Rita Raddatz

Angelo Parini

Dopamine D4 Receptors May Alleviate Antipsychotic-Induced Parkonsonism

478

(4)

P. Seeman

R. Corbett

H. H. M. Van Tol

Binding of Typical and Atypical Antipsychotic Drugs to Multiple Neurotransmitter Receptors

482

(4)

Bryan L. Roth

H. Y. Meltzer

Naseem Khan

Structural and Functional Characteristics of the Dopamine D4 Receptor

486

(4)

Hubert H. M. Van Tol

NGD 94-1: A Specific Dopamine-4-Receptor Antagonist

490

(3)

John F. Tallman

Catecholamine Receptors in Physiology and Behavior

493

(32)

In Vivo Mutation of the Alpha(2A)-Adrenergic Receptor by Homologous Recombination Reveals the Role of This Receptor Subtype in Multiple Physiological Processes

493

(3)

L. B. MacMillan

P. Lakhlani

L. Hein

M. Piascik

T. Z. Guo

D. Lovinger

M. Maze

L. E. Limbird

Regulation of Fat-Cell Function by Alpha(2)-Adrenergic Receptors

496

(3)

M. Lafontan

S. Betuing

J-S. Saulnier-Blache

P. Valet

A. Bouloumie

C. Carpene

J. Galitzky

M. Berlan

The Developmental and Physiological Consequences of Disrupting Genes Encoding Beta(1) and Beta(2) Adrenoceptors

499

(3)

D. K. Rohrer

D. Bernstein

A. Chruscinski

K. H. Desai

E. Schauble

B. K. Kobilka

Myocardial Overexpression of Adrenergic Receptors and Receptor Kinases

502

(5)

Walter J. Koch

Robert J. Lefkowitz

Carmelo A. Milano

Shahab A. Akhter

Howard A. Rockman

Cardiac G-Protein Receptor Kinase Activity: Effect of a Beta-Adrenergic Receptor Antagonist

507

(4)

H. Kirk Hammond

Peipei Ping

Paul A. Insel

Structure and Function of the Beta(3) Adrenoceptor

511

(3)

A. Donny Strosberg

Behavioral Analysis of Multiple D1-Like Dopamine Receptor Subtypes: New Agents and Studies in Transgenic Mice with D1A Receptor Knockout

514

(3)

J. L. Waddington

A. M. Deveney

J. Clifford

O. Tighe

D. T. Croke

D. R. Sibley

J. Drago

Antisense Knockdown of Brain Dopamine Receptors

517

(4)

Ian Creese

J. M. Tepper

The Physiological Role of Dopamine D2 Receptors

521

(4)

Adolfo Saiardi

Tarek Abdel Samad

Roberto Picetti

Yuri Bozzi

Ja-Hyun Baik

Emiliana Borrelli

Pathophysiological States

525

(4)

Regulation of D1 Receptor Function in Spontaneous Hypertension

525

(4)

Pedro A. Jose

Gilbert M. Eisner

Robin A. Felder

PART E CATECHOLAMINES IN THE PERIPHERY

529

(126)

Overview

529

(11)

David S. Goldstein

Assessment of Peripheral Catecholaminergic Function

540

(12)

*Peripheral Catecholaminergic Function Evaluated by Norepinephrine Measurements in Plasma, Extracellular Fluid, and Lymphocytes, from Nerve Recordings and Cellular Responses

540

(4)

Niels Juel Christensen

Jens H. Knudsen

Cardiac Microdialysis

544

(4)

P. M. Mertes

Sympathetic Microneurography and Neurocirculatory Function: Studies of Ventricular Arrhythmias in Humans

548

(4)

Robert F. Rea

Catecholamines and Stress

552

(15)

Stress as a Medical and Scientific Idea and Its Implications

552

(4)

George P. Chrousos

*Stressor Specificity of Peripheral Catecholaminergic Activation

556

(5)

R. Kvetnansky

K. Pacak

E. L. Sabban

I. J. Kopin

D. S. Goldstein

*Stressor-Specific Activation of Catecholaminergic Systems: Implications for Stress-Related Hypothalamic-Pituitary-Adrenocortical Responses

561

(3)

Karel Pacak

Judit S. Baffi

Richard Kvetnansky

David S. Goldstein

Miklos Palkovits

*Regulation of Gene Expression of Catecholamine Biosynthetic Enzymes by Stress

564

(3)

E. L. Sabban

B. B. Nankova

L. I. Serova

B. Hiremagalur

M. Rusnak

E. Saez

B. Spiegelman

R. Kvetnansky

Catecholamines and Pain

567

(16)

Peripheral Modulatory Effects of Catecholamines in Inflammatory and Neuropathic Pain

567

(5)

Srinivasa N. Raja

*Brain Catecholamine Systems in Stress

572

(3)

M. Palkovits

J. S. Baffi

Z. Toth

K. Pacak

Alpha(2)-Adrenergic Mechanisms of Analgesia: Strategies for Improving Their Therapeutic Window and Identification of the Novel, Potent Alpha(2A)-Adrenergic Receptor Agonist, S 18616

575

(4)

Mark J. Millan

Cellular Transplantation for Intractable Pain

579

(4)

Jacqueline Sagen

Catecholamines and Neuroimmunology

583

(12)

The Role of the Sympathetic Nervous System in the Modulation of Immune Responses

583

(4)

S. Y. Felten

K. S. Madden

D. L. Bellinger

B. Kruszewska

J. A. Moynihan

D. L. Felten

Catecholamines, Catecholamine Receptors, Cell Adhesion Molecules, and Acute Stressor-Related Changes in Cellular Immunity

587

(4)

Paul J. Mills

Michael G. Ziegler

Jalees Rehman

Alan S. Maisel

Nerve Growth Factor and Autoimmune Disease: Role of Tumor Necrosis Factor-Alpha?

591

(4)

Luigi Aloe

Adrenomedullary Secretion and Co-Secretion

595

(12)

Multiple Transmitter Control of Catecholamine Secretion in Rat Adrenal Medulla

595

(4)

Arun R. Wakade

Adrenomedullin in Cardiovascular Disease

599

(5)

Toshio Nishikimi

*Strychnine, Glycine, and Adrenomedullary Secretion

604

(3)

Gal Yadid

Yigal Fraenkel

Eliahu Golomb

Neurocardiology

607

(13)

*Catecholamines and Neurocardiogenic Syncope

607

(4)

J. W. M. Lenders

M. C. Jacobs

Th. Thien

D. S. Goldstein

*Beta-Blockers in Congestive Heart Failure: The Pharmacology of Carvedilol, a Vasodilating Beta-Blocker and Antioxidant, and Its Therapeutic Utility in Congestive Heart Failure

611

(4)

Gloria Feuerstein

Robert R. Ruffolo, Jr.

*Sympathetic Cardioneurotherapy in Dysautonomias

615

(5)

David S. Goldstein

Courtney Holmes

Richard O. Cannon, III

Graeme Eisenhofer

Irwin J. Kopin

Catecholamines and Metabolism

620

(18)

Hypoglycemia-Associated Autonomic Failure in Insulin-Dependent Diabetes Mellitus

620

(2)

Philip E. Cryer

Mechanisms of the Sympathoadrenal Response to Hypoglycemia

622

(5)

D. G. Maggs

R. S. Sherwin

Importance of Catecholamines in Defense against Insulin Hypoglycemia in Humans

627

(3)

Geremia B. Bolli

*Sympathetic Nervous Activity and the Thermic Effect of Food in Humans

630

(4)

M. Vaz

M. D. Esler

H. S. Cox

G. L. Jennings

D. M. Kaye

A. G. Turner

Microdialysis for the Assessment of Catecholamine-Induced Lipolysis in Human Adipose and Skeletal Muscle Tissue

634

(4)

Eva Hagstrom-Toft

Catecholamines in the Brain and Regulation of the Cardiovascular System

638

(17)

Bulbospinal C1-Adrenergic Neurons: Electrophysiological Properties in the Neonate Rat

638

(4)

Patrice G. Guyenet

Yu Wen Li

Donghai Huangfu

Ann M. Schreihofer

Catecholamines, Opioids, and Vagal Afferents in the Nucleus of the Solitary Tract

642

(3)

Virginia M. Pickel

Sue A. Aicher

Chiye Aoki

Peter Y. Cheng

Melissa J. Nirenberg

Agmatine: A Novel Neurotransmitter?

645

(5)

D. J. Reis

S. Regunathan

*Central and Peripheral Norepinephrine Kinetics in Heart Failure, Coronary Artery Disease, and Hypertension

650

(5)

M. Esler

G. Lambert

G. Jennings

A. Turner

D. Kaye

PART F CATECHOLAMINES IN THE CENTRAL NERVOUS SYSTEM

655

(164)

Overview

655

(15)

A. A. Grace

C. R. Gerfen

G. Aston-Jones

Dopamine-Mediated Gene Regulation in the Striatum

670

(4)

Charles R. Gerfen

Kristen A. Keefe

Heinz Steiner

Dopamine Control of Gene Expression in Basal Ganglia Nuclei: Striatal and Nonstriatal Mechanisms

674

(4)

M-F. Chesselet

J. M. Delfs

L. Mackenzie

Dopaminergic Regulation of Immediate Early Gene Expression in the Basal Ganglia

678

(4)

John F. Marshall

David N. Ruskin

Gerald J. LaHoste

Dopamine and Calcium Signal Interactions in the Developing Striatum: Control by Kinetics of CREB Phosphorylation

682

(4)

Fu-Chin Liu

Ann M. Graybiel

The Phasic Reward Signal of Primate Dopamine Neurons

686

(5)

Wolfram Schultz

Afferent Control of Midbrain Dopamine Neurons: An Intracellular Perspective

691

(3)

Steven W. Johnson

GABAergic Control of the Firing Pattern of Substantia Nigra Dopaminergic Neurons

694

(6)

J. M. Tepper

C. A. Paladini

P. Celada

Afferent Control of Substantia Nigra Compacta Dopamine Neurons: Anatomical Perspective and Role of Glutamatergic and Cholinergic Inputs

700

(3)

S. T. Kitai

Dopamine Axons in Primate Prefrontal Cortex: Specificity of Distribution, Synaptic Targets, and Development

703

(4)

David A. Lewis

Susan R. Sesack

Allan I. Levey

David R. Rosenberg

The Cortical Dopamine System: Role in Memory and Cognition

707

(5)

Patricia S. Goldman-Rakic

Norepinephrine-Dopamine Interactions in the Prefrontal Cortex and the Ventral Tegmental Area: Relevance to Mental Diseases

712

(5)

Jean-Pol Tassin

Dopamine Function in the Prefrontal Cortex

717

(4)

A. M. Thierry

S. Pirot

Y. Gioanni

J. Glowinski

*The Modulation of Corticoaccumbens Transmission by Limbic Afferents and Dopamine: A Model for the Pathophysiology of Schizophrenia

721

(3)

Anthony A. Grace

Holly Moore

Patricio O'Donnell

Dopamine Modulation of Responses Mediated by Excitatory Amino Acids in the Neostriatum

724

(5)

Michael S. Levine

Carlos Cepeda

The Molecular Basis of Dopamine and Glutamate Interactions in the Striatum

729

(4)

Christine Konradi

Modulation by Dopamine of Rat Corticostriatal Input

733

(4)

G. W. Arbuthnott

C. A. Ingham

J. R. Wickens

Dopamine, Glutamate, and Behavioral Correlates of Striatal Neuronal Activity

737

(3)

George V. Rebec

State-Related Activity, Reactivity of Locus Ceruleus Neurons in Behaving Monkeys

740

(4)

J. Rajkowski

P. Kubiak

S. Ivanova

G. Aston-Jones

Modulation of Forebrain Electroencephalographic Activity and Behavioral State by the Locus Ceruleus-Noradrenergic System: Involvement of the Medial Septal Area

744

(5)

Craig W. Berridge

New Perspectives on the Functional Organization and Postsynaptic Influences of the Locus Ceruleus Efferent Projection System

749

(6)

Barry D. Waterhouse

David Devilbiss

Daniel Fleischer

Francis M. Sessler

Kimberly L. Simpson

Neuromodulation and Cognitive Performance: Recent Studies of Noradrenergic Locus Ceruleus in Behaving Monkeys

755

(4)

G. Aston-Jones

J. Rajkowski

S. Ivanova

M. Usher

J. Cohen

Noradrenergic Effects on Activity of Prefrontal Cortical Neurons in Behaving Monkeys

759

(5)

T. Sawaguchi

Y. Kikuchi

Noradrenergic Influences on Prefrontal Cortical Cognitive Function: Opposing Actions at Postjunctional Alpha(1)-Versus Alpha(2)-Adrenergic Receptors

764

(3)

A. F. T. Arnsten

J. C. Steere

D. J. Jentsch

B. M. Li

Afferent Control of Nucleus Locus Ceruleus: Differential Regulation by "Shell" and "Core" Inputs

767

(5)

M. Ennis

M. T. Shipley

G. Aston-Jones

J. T. Williams

Sensory Response of the L'ocus Ceruleus: Neonatal and Adult Studies

772

(5)

S. Nakamura

S. Nishiike

Y. Fujii

N. Takeda

T. Kubo

Noradrenergic Modulation of the Prefrontal Cortex as Revealed by Electron Microscopic Immunocytochemistry

777

(4)

Chiye Aoki

Charu Venkatesan

Hitoshi Kurose

Activation of the Locus Ceruleus Brain Noradrenergic System during Stress: Circuitry, Consequences, and Regulation

781

(4)

Rita J. Valentino

Andre L. Curtis

Michelle E. Page

Luis A. Pavcovich

Sandra M. Florin-Lechner

*Norepinephrine and Schizophrenia: A New Hypothesis for Antipsychotic Drug Action

785

(3)

Alan Breier

Igor Elman

David S. Goldstein

Neurochemical Responses to Lesions of Dopaminergic Neurons: Implications for Compensation and Neuropathology

788

(4)

Michael J. Zigmond

Teresa G. Hastings

Dopamine Receptor Subtypes as Targets for the Pharmacotherapy of Parkinson's Disease

792

(4)

G. Andringa

R. J. Vermeulen

B. Drukarch

J. C. Stoof

A. R. Cools

*Free Radicals and MPTP-Induced Selective Destruction of Substantia Nigra Compacta Neurons

796

(5)

Chuang C. Chiueh

Pekka Rauhala

*Application of Gene Therapy for Parkinson's Disease: Nonhuman Primate Experience

801

(5)

K. S. Bankiewicz

J. R. Bringas

W. McLaughlin

P. Pivirotto

R. Hundal

B. Yang

M. E. Emborg

D. Nagy

Prefrontal Cortical and Hippocampal Modulation of Dopamine-Mediated Effects

806

(4)

Barbara K. Lipska

Daniel R. Weinberger

Dysregulation of Mesoprefrontal Dopamine Neurons Induced by Acute and Repeated Phencyclidine Administration in the Nonhuman Primate: Implications for Schizophrenia

810

(4)

J. David Jentsch

John D. Elsworth

Jane R. Taylor

D. Eugene Redmond, Jr.

Robert H. Roth

Interactions between Catecholamines and Serotonin: Relevance to the Pharmacology of Schizophrenia

814

(5)

T. H. Svensson

J. M. Mathe

G. G. Nomikos

B. Schilstrom

M. Marcus

M. Fagerquist

PART G NOVEL CATECHOLAMINERGIC SYSTEMS

819

(58)

Overview

819

(5)

David S. Goldstein

Catecholestrogens

824

(19)

Catecholestrogens in the Induction of Tumors in the Kidney of the Syrian Hamster

824

(4)

Joachim G. Liehr

*Biosynthesis and Inactivation of Catecholestrogens

828

(5)

J. Weisz

G. A. Clawson

C. R. Creveling

Catecholestrogens as Procarcinogens: Depurinating Adducts and Tumor Initiation

833

(4)

D. E. Stack

E. L. Cavalieri

E. G. Rogan

Role of Aromatic Hydrocarbons in Disclosing How Catecholestrogens Initiate Cancer

837

(3)

E. L. Cavalieri

E. G. Rogan

Embryo Implantation Requires Estrogen-Directed Uterine Preparation and Catecholestrogen-Mediated Embryonic Activation

840

(3)

B. C. Paria

S. K. Das

S. K. Dey

Nonneuronal Biosynthesis of Catecholamines

843

(12)

*Extra-Adrenal Nonneuronal Epinephrine and Phenylethanolamine-N-methyltransferase

843

(3)

Michael G. Ziegler

Brian P. Kennedy

Frederick W. Houts

Dopamine and the Brain-Gut Axis

846

(5)

Gunnar Flemstrom

Bengt Safsten

Lars Knutson

Origin and Significance of Plasma Dihydroxyphenylalanine

851

(4)

Ebbe Eldrup

Erik A. Richter

Merete L. Hetland

Jan Andreasen

Jannik Hilsted

Svend E. Moller

Niels Juel Christensen

Is L-Dopa a Neurotransmitter?

855

(11)

Is L-Dopa a Neurotransmitter of the Primary Baroreceptor Afferents Terminating in the Nucleus Tractus Solitarri of Rats?

855

(4)

Y. Misu

Y. Goshima

J-L. Yue

T. Miyamae

Immunocytochemical Evidence of Novel Catecholamine-or Biopterin-Related Neurons of Mammalian Brain

859

(3)

I. Nagatsu

M. Sakai

N. Karasawa

T. Takeuchi

R. Arai

K. Yamada

T. Nagatsu

Fluorinated Dihydroxyphenylserines as Potential Biological Precursors of Fluorinated Norepinephrines

862

(4)

B-H. Chen

J-Y. Nie

M. Singh

R. Davenport

V. W. Pike

K. L. Kirk

Dopamine as a Renal Autocrine-Paracrine Substance

866

(11)

Nonneuronal Dopamine

866

(4)

P. Soares-da-Silva

M. A. Vieira-Coelho

The Renal Dopamine System

870

(3)

Anita Aperia

Ann-Christine Eklof

Ulla Holtback

Susana Nowicki

Martin Sundlof

Paul Greengard

Renal Dopamine Production and Release in the Rat: A Microdialysis Study

873

(4)

Robert M. Carey

Zhi-Qin Wang

Helmy M. Siragy

Robin A. Felder

PART H DEVELOPMENT AND PLASTICITY

877

(92)

Overview

877

(6)

Joan P. Schwartz

Inductive Interactions Underlie Neural Crest Formation

883

(4)

Marianne Bronner-Fraser

Lineage Commitment and Fate of Neural Crest-Derived Neurogenic Cells

887

(4)

James A. Weston

The Differentiation of the Neurotransmitter Phenotypes in Chick Sympathetic Neurons

891

(4)

Hermann Rohrer

Uwe Ernsberger

Developmental Regulation of Neurotransmitters in Sympathetic Neurons

895

(4)

Guy L. Guidry

Story C. Landis

Changes in Gene Expression in Adult Sympathetic Neurons after Axonal Injury

899

(4)

R. Zigmond

R. Mohney

R. Schreiber

A. Shadiack

Y. Sun

Y. S. Vaccariello

Y. Zhou

Ontogeny of Vesicular Amine Transporter Expression in the Rat: New Perspectives on Aminergic Neuronal and Neuroendocrine Differentiation

903

(5)

B. Schutz

M. K-H. Schafer

L. E. Eiden

E. Weihe

Specification and Survival of Dopaminergic Neurons in the Mammalian Midbrain

908

(3)

Arnon Rosenthal

Effects of Glial Cell Line-Derived Neurotrophic Factor on the Nigrostriatal Dopamine System in Rodents and Nonhuman Primates

911

(4)

Don M. Gash

Greg A. Gerhardt

Barry J. Hoffer

Cell Body Functions of Brain-Derived Neurotrophic Factor Increase Forebrain Dopamine Release and Serotonin Metabolism Determined with in Vivo Microdialysis

915

(6)

C. Anthony Altar

Michelle Fritsche

Ronald M. Lindsay

Neurotrophin Modulation of Hippocampal Synaptic Transmission

921

(4)

Eric S. Levine

Ira B. Black

Mark R. Plummer

*Genotype and Phenotype in Familial Dysautonomia

925

(4)

F. B. Axelrod

D. Goldstein

C. Holmes

I. J. Kopin

A Gene Therapy Approach for the Treatment of Amyotrophic Lateral Sclerosis and Parkinson's Disease

929

(3)

A. D. Zurn

J. L. Tseng

N. Deglon

J. M. Joseph

P. Aebischer

Characterization of Adrenal Chromaffin Progenitor Cells in Mice

932

(4)

Frauke Deimling

Susetta Finotto

Karin Lindner, Barbara Bruhl

Jose L. Roig-Lopez

Jose E. Garcia-Arraras

Christo Goridis

Kerstin Krieglstein

Klaus Unsicker

Evolution and Origin of the Diversity of Dopamine Receptors in Vertebrates

936

(4)

B. Cardinaud

J-M. Gibert

F. Liu

K. S. Sugamori

J-D. Vincent

H. B. Niznik

P. Vernier

Neurogenetics of Synaptic Transmission in Caenorhabditis elegans

940

(5)

James B. Rand

Janet S. Duerr

Dennis L. Frisby

Decapitated Drosophila: A Novel System for the Study of Biogenic Amines

945

(4)

Jay Hirsch

Dopaminergic Control of Serotonergic Neuron Development in the Grasshopper Central Nervous System

949

(3)

Barry Condron

Kai Zinn

Noradrenergic Long-Term Potentiation in the Dentate Gyrus

952

(4)

Carolyn W. Harley

Rapid Acquisition of Discriminative Responding in Monkey Locus Coeruleus Neurons

956

(5)

P. Kubiak

J. Rajkowski

S. Ivanova

G. Aston-Jones

Catecholaminergic Contributions to Early Learning

961

(3)

Michael Leon

Interactions between Catecholamines and the Amygdala in Emotional Memory: Subclinical and Clinical Evidence

964

(5)

Larry Cahill

PART I DRUG ABUSE AND ALCOHOLISM

969

(78)

Overview

969

(9)

G. F. Koob

Circuits, Drugs, and Drug Addiction

978

(5)

George F. Koob

Homologies and Differences in the Actions of Drugs of Abuse and a Conventional Reinforcer (Food) on Dopamine Transmission: An Interpretative Framework of the Mechanism of Drug Dependence

983

(4)

Gaetano Di Chiara

Gianluigi Tanda

Cristina Cadoni

Elio Acquas

Valentina Bassareo

Ezio Carboni

Drug-Induced Adaptations in Catecholamine Systems: On the Inevitability of Sensitization

987

(4)

Terry E. Robinson

Aldo Badiani

Neurobiological Substrates Underlying Conditioned Effects of Cocaine

991

(4)

Agu Pert

The Rate Hypothesis and Agonist Substitution Approaches to Cocaine Abuse Treatment

995

(3)

David A. Gorelick

Drugs of Abuse and Dopamine Cell Activity

998

(4)

Marco Diana

D1-Receptor Regulation of Synaptic Potentials in the Ventral Tegmental Area after Chronic Drug Abuse

1002

(4)

C. D. Fiorillo

J. T. Williams

A. Bonci

Neuroadaptations in Nucleus Accumbens Neurons Resulting from Repeated Cocaine Administration

1006

(4)

Francis J. White

Xiu-Ti Hu

Xu-Feng Zhang

Dopamine Efflux Studies into the in Vivo Actions of Psychostimulant Drugs

1010

(4)

Y. L. Hurd

M. Ponten

A. MacGregor

T. Guix

U. Ungerstedt

Psychostimulants and Neuropeptide Response

1014

(3)

Glen R. Hanson

John D. Wagstaff

Kalpana Merchant

James W. Gibb

Drugs of Abuse and Striatal Gene Expression

1017

(3)

Jacqueline F. McGinty

John Q. Wang

Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons

1020

(4)

D. James Surmeier

Zhen Yan

Wen-Jie Song

Dopaminergic Genes and Substance Abuse

1024

(9)

George R. Uhl

David J. Vandenbergh

Lawrence A. Rodriguez

Lucinda Miner

Nobuyuki Takahashi

Quantitative Trait Loci: Mapping Drug and Alcohol-Related Genes

1033

(4)

John C. Crabbe

John K. Belknap

Pamela Metten

Judith E. Grisel

Kari J. Buck

Nuclear Memory: Gene Transcription and Behavior

1037

(5)

N. Hiroi

E. J. Nestler

Phosphorylation of Dopamine Transporters and Rapid Adaptation to Cocaine

1042

(5)

Roxanne A. Vaughan

Robin A. Huff

George R. Uhl

Michael J. Kuhar

Index

1047

(24)

Contents of Previous Volumes

1071

*These chapters present current findings in catecholamine research by the many scientists whose lives have been touched by Dr. Irwin J. Kopin

Please wait while the item is added to your bag...

FREE SHIPPING

Rent More, Save More! Use code: BBRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

Advances in Pharmacology: Catecholamines Bridging Basic Science with Clinical Medicine

Summary

Table of Contents

Supplemental Materials

FREE SHIPPING

Rent More, Save More! Use code: BBRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

Advances in Pharmacology: Catecholamines Bridging Basic Science with Clinical Medicine

Summary

Table of Contents

Supplemental Materials

Digital License